We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

202 hedge funds and large institutions have $4.01B invested in Arcellx in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 82 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 24

3% more funds holding

Funds holding: 197202 (+5)

0.69% less ownership

Funds ownership: 112.09%111.39% (-0.69%)

1% less capital invested

Capital invested by funds: $4.04B → $4.01B (-$32.5M)

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

26% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 82

68% less call options, than puts

Call options by funds: $18.7M | Put options by funds: $58.5M

Holders
202
Holders Change
+5
Holders Change %
+2.54%
% of All Funds
2.66%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
30
Increased
61
Reduced
82
Closed
24
Calls
$18.7M
Puts
$58.5M
Net Calls
-$39.8M
Net Calls Change
-$72M
Name Holding Trade Value Shares
Change
Change in
Stake
GS
1
Gilead Sciences
California
$443M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$393M -$20.6M -331,528 -5%
PBA
3
Paradigm Biocapital Advisors
New York
$306M +$9.77M +156,984 +3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$260M -$2.51M -40,271 -1%
NMC
5
NEA Management Company
Maryland
$247M
BlackRock
6
BlackRock
New York
$228M -$31.1M -499,385 -13%
RCM
7
RA Capital Management
Massachusetts
$200M
VPC
8
Vestal Point Capital
New York
$181M +$22.6M +362,280 +15%
PA
9
Perceptive Advisors
New York
$163M -$27.9M -448,478 -15%
SOCM
10
SR One Capital Management
Pennsylvania
$155M
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$128M +$17.3M +278,588 +17%
State Street
12
State Street
Massachusetts
$105M -$4.62M -74,138 -4%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$94.7M -$25M -400,851 -22%
AIIC
14
AJU IB Investment Company
South Korea
$69M
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$67.4M -$30.3M -486,912 -32%
JP Morgan Chase
16
JP Morgan Chase
New York
$64.3M +$18.3M +293,387 +43%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$63.3M -$3.66M -58,762 -6%
CAM
18
Cormorant Asset Management
Massachusetts
$52.7M -$15.6M -250,000 -24%
Capital World Investors
19
Capital World Investors
California
$51.6M +$4.58M +73,637 +10%
BAMCO Inc
20
BAMCO Inc
New York
$34.1M +$3.16M +50,748 +11%
Morgan Stanley
21
Morgan Stanley
New York
$34.1M +$3.44M +55,180 +12%
Goldman Sachs
22
Goldman Sachs
New York
$33.6M +$20.9M +335,817 +192%
AAA
23
Affinity Asset Advisors
New York
$32.6M -$2.18M -35,000 -7%
American Century Companies
24
American Century Companies
Missouri
$28.4M +$23.5M +377,145 +694%
Pictet Asset Management
25
Pictet Asset Management
Switzerland
$25.2M +$23.5M +377,649 +6,883%

ACLX Hedge Fund Activity: Q2 2025 in Review

202 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q2 2025, worth a combined $4.01B — down 0.8% from $4.04B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ACLX positions and 24 closed out — a net gain of 6 holders — while 61 added to existing stakes and 82 trimmed.

The largest buyer was Decheng Capital, adding an estimated $31M. The largest seller was Citadel Advisors, cutting an estimated $32.9M.

  • 202 institutional investors held Arcellx (ACLX) as of Q2 2025, up from 197 in Q1 2025.
  • Funds reported $4.01B of Arcellx stock for Q2 2025, down 0.8% quarter-over-quarter.
  • 30 funds opened new Arcellx positions in Q2 2025 and 24 closed out, a net change of +6 holders.
  • The largest Arcellx buyer in Q2 2025 was Decheng Capital, an estimated $31M added.
  • The largest Arcellx seller in Q2 2025 was Citadel Advisors, an estimated $32.9M sold.

Based on aggregated 13F filings for Q2 2025.